NEXGEL (NXGL) Stock Price, News & Analysis

Company Overview

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Key Stats

• Today's Range: $3.30 to $3.66
• 50-Day Range: $3.19 to $4.93
• 52-Week Range: $1.84 to $5.10
• Volume: 103,201 shs
• Average Volume: 61,318 shs
• Market Capitalization: $22.54 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NXGL Stock Analysis - Frequently Asked Questions

How have NXGL shares performed this year?

NEXGEL's stock was trading at $4.46 at the beginning of 2025. Since then, NXGL stock has decreased by 25.6% and is now trading at $3.32.
View the best growth stocks for 2025 here.

How were NEXGEL's earnings last quarter?

NEXGEL, Inc. (NASDAQ:NXGL) announced its earnings results on Monday, March, 27th. The company reported ($0.11) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.04. The firm earned $0.52 million during the quarter. NEXGEL had a negative trailing twelve-month return on equity of 71.19% and a negative net margin of 52.60%.

When did NEXGEL IPO?

NEXGEL (NXGL) raised $14 million in an IPO on Wednesday, December 22nd 2021. The company issued 2,100,000 shares at $6.83 per share. Maxim Group LLC served as the underwriter for the IPO.

Who are NEXGEL's major shareholders?

Top institutional shareholders of NEXGEL include Renaissance Technologies LLC (2.33%), Geode Capital Management LLC (0.89%), Two Sigma Securities LLC (0.18%) and IFP Advisors Inc (0.16%). Insiders that own company stock include John Nachum Stein, Nachum Stein, Adam R Levy, Steven Mark Glassman, Scott Robert Henry, Adam E Drapczuk III and David Stefansky.
View institutional ownership trends.

How do I buy shares of NEXGEL?

Shares of NXGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NEXGEL own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NEXGEL investors own include Lexicon Pharmaceuticals (LXRX), Aditxt (ADTX), Helius Medical Technologies (HSDT), Onconova Therapeutics (ONTX), EchoStar (SATS), American Battery Technology (ABML) and Aumann (AAG).

Company Calendar

• Last Earnings: 3/27/2023
• Today: 2/22/2025
• Next Earnings (Estimated): 4/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NXGL
• CUSIP: N/A
• CIK: 1468929
• Web: nexgel.com
• Phone: 215-702-8550
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.58)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-3,160,000.00
• Net Margins: -52.60%
• Pretax Margin: -56.85%
• Return on Equity: -71.19%
• Return on Assets: -34.79%

Debt

• Debt-to-Equity Ratio: 0.19
• Current Ratio: 1.51
• Quick Ratio: 0.93

Sales & Book Value

• Annual Sales: $4.09 million
• Price / Sales: 5.51
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.90 per share
• Price / Book: 3.69

Miscellaneous

• Outstanding Shares: 6,790,000
• Free Float: 5,103,000
• Market Cap: $22.54 million
• Optionable: Not Optionable
• Beta: 0.57